Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MEN1 | O00255 | 2/20 | 0.44 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.44 |
| ▸ | PSMB5 | P28074 | 1/20 | 0.37 |
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.36 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.36 |
| ▸ | HPGD | P15428 | 1/20 | 0.36 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.35 |
| ▸ | DRD3 | P35462 | 1/20 | 0.35 |
| ▸ | SLC6A3 | Q01959 | 1/20 | 0.35 |
| ▸ | MTNR1A | P48039 | 3/20 | 0.35 |
| ▸ | MTNR1B | P49286 | 3/20 | 0.35 |
| ▸ | HTR2C | P28335 | 2/20 | 0.35 |
| ▸ | EGFR | P00533 | 1/20 | 0.34 |
| ▸ | SRC | P12931 | 1/20 | 0.34 |
| ▸ | GAA | P10253 | 1/20 | 0.33 |
| ▸ | MAPT | P10636 | 1/20 | 0.33 |
| ▸ | DUSP3 | P51452 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL12719510 | 1.00 | MEN1 (0.44) | MEN1KMT2APSMB5LMNACYP2C19 | |
| SCHEMBL15943619 | 1.00 | MEN1 (0.44) | MEN1KMT2APSMB5LMNACYP2C19 | |
| SCHEMBL19455924 | 0.90 | MEN1 (0.40) | MEN1KMT2APSMB5LMNACYP2C19 | |
| SCHEMBL19661531 | 0.90 | MEN1 (0.40) | MEN1KMT2APSMB5LMNACYP2C19 | |
| SCHEMBL3692879 | 0.84 | MEN1 (0.46) | MEN1KMT2APSMB5LMNACYP2C19 | |
| SCHEMBL29638822 | 0.83 | LMNA (0.40) | MEN1KMT2ALMNACYP2C19HIF1A | |
| SCHEMBL12122298 | 0.83 | CASP2 (0.44) | MEN1KMT2APSMB5LMNAALDH1A1 | |
| SCHEMBL22429690 | 0.82 | MEN1 (0.38) | MEN1KMT2APSMB5KDM4ECYP2C9 | |
| SCHEMBL22429688 | 0.82 | MEN1 (0.38) | MEN1KMT2APSMB5KDM4ECYP2C9 | |
| SCHEMBL1709105 | 0.82 | MEN1 (0.38) | MEN1KMT2APSMB5CYP2C9MTNR1A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 37 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-103524678-B | Liquid crystal elastic body composite for optical actuator and preparation method thereof | 湖北大学 | 2016-08-31 | — | — | CN | claimed |
| CN-101344735-A | Hollow toner and process of preparing the same | SAMSUNG ELECTRONICS CO LTD (KR) | 2009-01-14 | — | — | CN | claimed |
| US-20210300940-A1 | TLR7/8 ANTAGONISTS AND USES THEREOF | MERCK PATENT GMBH (DE) | 2021-09-30 | — | — | US | disclosed |
| US-10745356-B2 | Compositions and methods for treating tuberculosis | THE BROAD INSTITUTE, INC. (US) | 2020-08-18 | — | — | US | disclosed |
| US-20190284140-A1 | COMPOSITIONS AND METHODS FOR TREATING TUBERCULOSIS | THE BROAD INSTITUTE, INC. | 2019-09-19 | — | — | US | disclosed |
| US-10251845-B2 | Fatty acid cysteamine conjugates and their use as activators of autophagy | CATABASIS PHARMACEUTICALS, INC. (US) | 2019-04-09 | — | — | US | disclosed |
| CN-108368090-A | Compounds as Immunomodulators | 百时美施贵宝公司 | 2018-08-03 | — | — | CN | disclosed |
| EP-3340979-A1 | COMPOSITIONS AND METHODS FOR DRUG SENSITIZATION OF PARASITES | The Texas A&M University System (US) | 2018-07-04 | — | — | EP | disclosed |
| US-20170258741-A1 | FATTY ACID CYSTEAMINE CONJUGATES AND THEIR USE AS ACTIVATORS OF AUTOPHAGY | CATABASIS PHARMACEUTICALS, INC. (US) | 2017-09-14 | — | — | US | disclosed |
| WO-2017035438-A1 | COMPOSITIONS AND METHODS FOR DRUG SENSITIZATION OF PARASITES | THE TEXAS A&M UNIVERSITY SYSTEM (US) | 2017-03-02 | — | — | WO | disclosed |
| CN-103524678-B | Liquid crystal elastic body composite for optical actuator and preparation method thereof | 湖北大学 | 2016-08-31 | — | — | CN | disclosed |
| CN-101013278-A | Method for preparing toner and toner prepared by using the method | SAMSUNG ELECTRONICS CO LTD (KR) | 2007-08-08 | — | — | CN | disclosed |
| CN-101008795-A | Method of preparing toner and toner prepared using the method | SAMSUNG ELECTRONICS CO LTD (KR) | 2007-08-01 | — | — | CN | disclosed |
| CN-1996154-A | Method for preparing toner and toner prepared by using the method | SAMSUNG ELECTRONICS CO LTD (KR) | 2007-07-11 | — | — | CN | disclosed |
| CN-1991598-A | Method for preparing toner and toner prepared by using the method | SAMSUNG ELECTRONICS CO LTD (KR) | 2007-07-04 | — | — | CN | disclosed |
| CN-1983042-A | Method of preparing toner and toner prepared using the method | SAMSUNG ELECTRONICS CO LTD (KR) | 2007-06-20 | — | — | CN | disclosed |
| CN-1971433-A | Method for preparing toner and toner prepared by using the method | SAMSUNG ELECTRONICS CO LTD (KR) | 2007-05-30 | — | — | CN | disclosed |
| CN-1971434-A | Method for preparing toner and toner prepared by using the method | SAMSUNG ELECTRONICS CO LTD (KR) | 2007-05-30 | — | — | CN | disclosed |
| CN-1928727-A | Method of preparing toner and toner prepared using the method | SAMSUNG ELECTRONICS CO LTD (KR) | 2007-03-14 | — | — | CN | disclosed |
| US-5514754-A | POLYMERIZATION OF ACRYLIC MONOMERS, NEUTRALIZATION AND GRINDING, SEPARATION, MIXING AND CROSSLINKING | AMERICAN COLLOID COMPANY (US) | 1996-05-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (5 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10745356-B2 | Compositions and methods for treating tuberculosis | C5, IFNG, TERT | MEN1 2513/4885KMT2A 3608/4885PSMB5 3200/4885 |
| US-20170258741-A1 | FATTY ACID CYSTEAMINE CONJUGATES AND THEIR USE AS ACTIVATORS OF AUTOPHAGY | NDUFAB1, ATG7, HADHA | MEN1 2656/4885KMT2A 1811/4885PSMB5 3680/4885 |
| US-20190284140-A1 | COMPOSITIONS AND METHODS FOR TREATING TUBERCULOSIS | C5, IFNG, TERT | MEN1 2513/4885KMT2A 3608/4885PSMB5 3200/4885 |
| US-10251845-B2 | Fatty acid cysteamine conjugates and their use as activators of autophagy | NDUFAB1, ATG7, NLN | MEN1 3093/4885KMT2A 2017/4885PSMB5 3791/4885 |
| US-20210300940-A1 | TLR7/8 ANTAGONISTS AND USES THEREOF | TLR7, TLR8, TLR9 | MEN1 4681/4885KMT2A 1065/4885PSMB5 3485/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.